Calton & Associates, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Calton & Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $179,222 - $216,551	-329 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $162,302 - $211,849	329 New	329 $206,000
Q1 2018 Apr 17, 2018	SELL	$315.82 - $393.78 $29,687 - $37,015	-94 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$358.63 - $469.95 $33,711 - $44,175	94	94 $35,000

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.